Interestingly, asymptomatic neurosyphilis patients display different levels of Aβ42 and tau in the CSF compared to AD patients, which could be used as a biomarker to differentiate between the diseases as well as to determine the stage of neurosyphilis in a patient [260]. This evidence concerns the gene MAPT and Alzheimer disease.